Home > Compound List > Product Information
Amifostine_Molecular_structure_CAS_20537-88-6)
Click picture or here to close

Amifostine

Catalog No. A5922 Name Sigma Aldrich
CAS Number 20537-88-6 Website http://www.sigmaaldrich.com
M. F. C5H15N2O3PS Telephone 1-800-521-8956
M. W. 214.222961 Fax
Purity ≥97% (TLC) Email
Storage Chembase ID: 1014

SYNONYMS

IUPAC name
({2-[(3-aminopropyl)amino]ethyl}sulfanyl)phosphonic acid
IUPAC Traditional name
amifostine
Synonyms
2-(3-Aminopropyl)aminoethyl phosphorothioate
WR2721

DATABASE IDS

PubChem SID 24278231
MDL Number MFCD00233058
CAS Number 20537-88-6

PROPERTIES

Empirical Formula (Hill Notation) C5H15N2O3PS
Purity ≥97% (TLC)
Apperance powder
GHS Pictograms GHS07
GHS Signal Word Warning
GHS Hazard statements H302
European Hazard Symbols Harmful Harmful (Xn)
MSDS Link Download
Personal Protective Equipment dust mask type N95 (US), Eyeshields, Gloves
Risk Statements 22
RTECS TE6491000
Safety Statements 26-36
Storage Temperature 2-8°C
German water hazard class 3

DETAILS

Description (English)
Application
Amifostine may provide renal protection during PRRT using somatostatin analogs by mitigating radiation damage and reducing the absorbed kidney radiation dose. Amifostine remediates the degenerative effects of radiation on the mineralization capacity of the murine mandible.
Biochem/physiol Actions
Radioprotective agent. Selectively protects normal tissues from the damaging effects of anti-neoplastic radiation therapy. Selectivity is due to preferential uptake by normal tissues and subsequent metabolic activation to 2-(3-aminopropyl)aminoethanethiol.
Description (简体中文)
Application
Amifostine may provide renal protection during PRRT using somatostatin analogs by mitigating radiation damage and reducing the absorbed kidney radiation dose. Amifostine remediates the degenerative effects of radiation on the mineralization capacity of the murine mandible.
Biochem/physiol Actions
Radioprotective agent. Selectively protects normal tissues from the damaging effects of anti-neoplastic radiation therapy. Selectivity is due to preferential uptake by normal tissues and subsequent metabolic activation to 2-(3-aminopropyl)aminoethanethiol.

REFERENCES